VERICEL CORPORATION (VCEL) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | 24.22M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $24.22M | (m) |
| 2026-03-31 | (m) | $21.46M | (m) |
| 2025-12-31 | (m) | $16.52M | (m) |
| 2025-09-30 | (m) | $13.08M | (m) |
| 2025-06-30 | (m) | $7.11M | (m) |
| 2025-03-31 | (m) | $2.98M | (m) |
| 2024-12-31 | (m) | $10.36M | (m) |
| 2024-09-30 | (m) | $3.55M | (m) |
| 2024-06-30 | (m) | $789.00K | (m) |
| 2024-03-31 | (m) | $451.00K | (m) |
| 2023-12-31 | (m) | $-3.18M | (m) |
| 2023-09-30 | (m) | $-10.25M | (m) |
| 2023-06-30 | (m) | $-13.17M | (m) |
| 2023-03-31 | (m) | $-17.11M | (m) |
| 2022-12-31 | (m) | $-16.71M | (m) |
| 2022-09-30 | (m) | $-18.10M | (m) |
| 2022-06-30 | (m) | $-16.45M | (m) |
| 2022-03-31 | (m) | $-11.27M | (m) |
| 2021-12-31 | (m) | $-7.47M | (m) |
| 2021-09-30 | (m) | $214.00K | (m) |
| 2021-06-30 | (m) | $8.76M | (m) |
| 2021-03-31 | (m) | $4.28M | (m) |
| 2020-12-31 | (m) | $2.86M | (m) |
| 2020-09-30 | (m) | $145.00K | (m) |
| 2020-06-30 | (m) | $-3.00K | (m) |
| 2020-03-31 | (m) | $-11.53M | (m) |
| 2019-12-31 | (m) | $-9.66M | (m) |
| 2019-09-30 | (m) | $-13.92M | (m) |
| 2019-06-30 | (m) | $-18.46M | (m) |
| 2019-03-31 | (m) | $-3.32M | (m) |
| 2018-12-31 | (m) | $-8.14M | (m) |
| 2018-09-30 | (m) | $-13.09M | (m) |
| 2018-06-30 | (m) | $-17.43M | (m) |
| 2018-03-31 | (m) | $-15.17M | (m) |
| 2017-12-31 | (m) | $-17.29M | (m) |
| 2017-09-30 | (m) | $-23.77M | (m) |
| 2017-06-30 | (m) | $-25.04M | (m) |
| 2017-03-31 | (m) | $-25.69M | (m) |
| 2016-12-31 | (m) | $-19.57M | (m) |
| 2016-09-30 | (m) | $-18.28M | (m) |
| 2016-06-30 | (m) | $-16.02M | (m) |
| 2016-03-31 | (m) | $-15.13M | (m) |
| 2015-12-31 | (m) | $-16.34M | (m) |
| 2015-09-30 | (m) | $-13.80M | (m) |
| 2015-06-30 | (m) | $-16.30M | (m) |
| 2015-03-31 | (m) | $-18.79M | (m) |
| 2014-12-31 | (m) | $-19.92M | (m) |
| 2014-09-30 | (m) | $-20.47M | (m) |
| 2014-06-30 | (m) | $-15.82M | (m) |
| 2014-03-31 | (m) | $-16.07M | (m) |
| 2013-12-31 | (m) | $-15.62M | (m) |
| 2013-09-30 | (m) | $-19.36M | (m) |
| 2013-06-30 | (m) | $-23.12M | (m) |
| 2013-03-31 | (m) | $-25.56M | (m) |
| 2012-12-31 | (m) | $-29.47M | (m) |
| 2012-09-30 | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) |
| 2011-12-31 | (m) | $-19.67M | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) |
| 2010-06-30 | (m) | $-14.56M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |